My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 742 / DOI: 10.3332/ecancer.2017.742

Special Issue

Professor Umberto Veronesi: a physician, a researcher, a brilliant man

Many of those who work in oncology or deal with cancer patients know of Prof. Umberto Veronesi and none of them could deny the importance of his battle against cancer.

He devoted his life to improving cancer treatment and quality of life for patients. He was a physician, and a politician, but above all he was a researcher. He embodied the true spirit of research, i.e., to believe in something and investigate every aspect of it until all the questions about it have been satisfactorily answered. He never gave up when faced with challenges, and he never stopped being curious. He believed in science, because he wanted to believe in the future. He mixed scientific knowledge with human warmth and was the pioneer of many breast cancer innovations.

From the beginning of Prof. Veronesi’s career, his mission was clear: ‘My first decision was to focus on the fight against cancer. When I started at the National Cancer Institute in Milan, I felt a profound sense of rebellion against the surrender of doctors and patients to a disease that caused intense suffering. In particular, I could not stand the havoc of a woman’s body after a mastectomy: in order to remove just a small breast cancer, not only the breast was taken away from the body, but also the axillary lymph nodes and the chest muscles. Consequently, I decided to fight mainly against breast cancer. It was a tough war: the dogma of mastectomy was so deeply-rooted that everybody thought I was crazy when I suggested conservative breast surgery.’

Keywords: breast cancer, patient-centred care, psychosocial aspects, medical decision-making, Umberto Veronesi

Loading Article Metrics ... Please wait

Related articles

Research: Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy

Abstract | Full Article | PDF Published: 15 Aug 2017 / DOI: 10.3332/ecancer.2017.759

Review: Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy

Abstract | Full Article | PDF Published: 06 Jul 2017 / DOI: 10.3332/ecancer.2017.751

Special Issue: The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

Abstract | Full Article | PDF Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.746

Special Issue: Radioguided localisation of non-palpable lesions of the breast in Costa Rica: Review of results of our first 800 patients in private practice

Abstract | Full Article | PDF | Spanish Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.745

Special Issue: Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO)

Abstract | Full Article | PDF Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.744



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence